Rish.Digh.Steel (531539)

Score breakdown: P/E: 1/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Strengths

• Trades slightly below book value: P/B of 0.98 and book value of ₹34.73 versus price of ₹34.00.
• Piotroski F-Score of 6/9 suggests some fundamental stability across profitability, leverage, and efficiency measures.
• Reported profit growth of 108% and PEG of 0.19 indicate trailing earnings momentum, though from a very small base.

Concerns

• Latest quarter shows sales of ₹0 Cr and net profit of ₹0 Cr—operations appear stalled or dormant.
• ROE of 5% and ROCE of 0.87% reflect very poor capital productivity and weak value creation.
• Sales growth is 0%, dividend yield is 0%, and P/E is 20.93—no growth, no income, and an expensive multiple for current earnings.
• Promoter holding and Debt/Equity are not disclosed, creating serious transparency and leverage risks.

AI Analysis

Let me look at Rish.Digh.Steel through Graham's lens. The stock trades at ₹34, which is slightly below book value of ₹34.73—a P/B of 0.98. That can be attractive if the assets are productive, but look at the earnings: ROE is only 5% and ROCE is 0.87%. Latest quarter sales and net profit are both zero. That is not a business; that is a shell waiting for an operator. Sales growth is 0%, dividend yield is 0%, and promoter holding is not disclosed. I cannot value a company when the people in control hide their own skin in the game. The 108% profit growth and PEG of 0.19 might tempt someone, but with zero quarterly numbers, this 'growth' is probably arithmetic noise from a tiny base. At P/E 20.93, paying 21 times earnings for a micro-cap with no topline momentum and negligible leveraged returns fails my margin of safety test. Book value gives some downside cushion, but book value can erode quickly if the business keeps earning 5% on equity and returns less than 1% on capital employed. Piotroski F-Score of 6/9 is mildly encouraging, but that is a hospital check, not a bill of health. Debt/equity is not available, so I can't gauge financial risk. The 52-week range of ₹28.50 to ₹43.95 and market cap of just ₹20 Cr tell me this is a speculative micro-cap. Buffett would say it's far better to buy a wonderful company at a fair price than a fair company at a wonderful price. Here I have a questionable company at a seemingly cheap price. For an Indian retail investor, I would insist on proof of renewed operations—positive quarterly sales and profit—before considering even a small position. This is an asset play with a stagnant business, not a compounder.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer